| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 13 | 2024 | 3627 | 2.050 |
Why?
|
| Extracorporeal Membrane Oxygenation | 8 | 2022 | 1462 | 1.120 |
Why?
|
| Nerve Block | 2 | 2024 | 705 | 1.000 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2022 | 128 | 0.750 |
Why?
|
| Pain, Postoperative | 5 | 2024 | 1738 | 0.730 |
Why?
|
| Analgesics, Opioid | 3 | 2024 | 3808 | 0.590 |
Why?
|
| Shock, Septic | 1 | 2020 | 769 | 0.430 |
Why?
|
| Heart Defects, Congenital | 5 | 2022 | 4673 | 0.370 |
Why?
|
| Acute Kidney Injury | 2 | 2019 | 1923 | 0.340 |
Why?
|
| Catheterization | 2 | 2005 | 1428 | 0.310 |
Why?
|
| Extracorporeal Circulation | 1 | 2008 | 181 | 0.300 |
Why?
|
| Postoperative Complications | 5 | 2022 | 15634 | 0.260 |
Why?
|
| Umbilical Arteries | 1 | 2005 | 76 | 0.250 |
Why?
|
| Hypoplastic Left Heart Syndrome | 2 | 2008 | 594 | 0.240 |
Why?
|
| Nicotinic Agonists | 2 | 2018 | 265 | 0.240 |
Why?
|
| alpha-Fetoproteins | 1 | 2004 | 223 | 0.220 |
Why?
|
| Anesthetics, Intravenous | 1 | 2006 | 394 | 0.220 |
Why?
|
| Cardiotonic Agents | 1 | 2006 | 540 | 0.220 |
Why?
|
| Aortic Coarctation | 2 | 2003 | 275 | 0.220 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2006 | 480 | 0.210 |
Why?
|
| Morphine Derivatives | 1 | 2021 | 42 | 0.200 |
Why?
|
| Teratoma | 1 | 2004 | 404 | 0.190 |
Why?
|
| Propofol | 1 | 2006 | 602 | 0.180 |
Why?
|
| Heart Neoplasms | 1 | 2004 | 364 | 0.180 |
Why?
|
| Pericardium | 1 | 2004 | 674 | 0.170 |
Why?
|
| Aortic Rupture | 1 | 2002 | 319 | 0.160 |
Why?
|
| Dopamine | 1 | 2006 | 1606 | 0.160 |
Why?
|
| Heart Block | 2 | 2011 | 385 | 0.160 |
Why?
|
| Retrospective Studies | 11 | 2024 | 80673 | 0.160 |
Why?
|
| Child, Preschool | 5 | 2024 | 42217 | 0.160 |
Why?
|
| Lung Transplantation | 2 | 2018 | 1307 | 0.160 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2005 | 695 | 0.160 |
Why?
|
| Length of Stay | 3 | 2022 | 6420 | 0.160 |
Why?
|
| Myocytes, Cardiac | 2 | 2006 | 1666 | 0.160 |
Why?
|
| Furosemide | 1 | 2019 | 170 | 0.150 |
Why?
|
| Treatment Outcome | 10 | 2024 | 64670 | 0.140 |
Why?
|
| Hemofiltration | 1 | 2017 | 59 | 0.140 |
Why?
|
| Ethics Committees | 1 | 2016 | 51 | 0.140 |
Why?
|
| Genetic Engineering | 1 | 2022 | 929 | 0.140 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2018 | 123 | 0.130 |
Why?
|
| Employment | 1 | 2022 | 1114 | 0.130 |
Why?
|
| Poisoning | 1 | 2017 | 252 | 0.130 |
Why?
|
| Shock | 1 | 2018 | 314 | 0.130 |
Why?
|
| Pheochromocytoma | 1 | 2018 | 328 | 0.130 |
Why?
|
| Goals | 1 | 2021 | 708 | 0.130 |
Why?
|
| Humans | 36 | 2024 | 761098 | 0.130 |
Why?
|
| Adrenal Glands | 1 | 2018 | 552 | 0.120 |
Why?
|
| Child | 7 | 2024 | 80134 | 0.120 |
Why?
|
| Survival Rate | 5 | 2021 | 12727 | 0.120 |
Why?
|
| Pacemaker, Artificial | 2 | 2011 | 807 | 0.120 |
Why?
|
| Smoking Cessation | 2 | 2018 | 2057 | 0.120 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2017 | 314 | 0.120 |
Why?
|
| Pulmonary Fibrosis | 1 | 2018 | 505 | 0.110 |
Why?
|
| Hemolysis | 1 | 2016 | 415 | 0.110 |
Why?
|
| Acute Coronary Syndrome | 2 | 2018 | 2191 | 0.110 |
Why?
|
| Apoptosis | 2 | 2006 | 9478 | 0.110 |
Why?
|
| Pain Measurement | 1 | 2024 | 3548 | 0.110 |
Why?
|
| Heart | 2 | 2022 | 4431 | 0.110 |
Why?
|
| Vascular Resistance | 1 | 2016 | 932 | 0.110 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2021 | 993 | 0.110 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2018 | 732 | 0.100 |
Why?
|
| Shock, Cardiogenic | 1 | 2018 | 709 | 0.100 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2018 | 1086 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 3594 | 0.100 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2016 | 1092 | 0.090 |
Why?
|
| Heart Arrest | 1 | 2021 | 1514 | 0.090 |
Why?
|
| Stents | 1 | 2002 | 3177 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2019 | 2135 | 0.090 |
Why?
|
| Prospective Studies | 4 | 2024 | 54419 | 0.090 |
Why?
|
| Cardiology | 1 | 2021 | 1693 | 0.080 |
Why?
|
| Specialties, Surgical | 1 | 2014 | 389 | 0.080 |
Why?
|
| Time Factors | 4 | 2024 | 39953 | 0.080 |
Why?
|
| Male | 17 | 2024 | 360675 | 0.080 |
Why?
|
| Female | 21 | 2024 | 392458 | 0.080 |
Why?
|
| Equipment Failure | 1 | 2011 | 579 | 0.080 |
Why?
|
| Hemodynamics | 2 | 2017 | 4164 | 0.080 |
Why?
|
| Myocardial Ischemia | 2 | 2011 | 2133 | 0.080 |
Why?
|
| Sheep | 1 | 2010 | 1436 | 0.070 |
Why?
|
| Aorta, Thoracic | 3 | 2010 | 1096 | 0.070 |
Why?
|
| Thrombosis | 1 | 2022 | 2944 | 0.070 |
Why?
|
| Pediatrics | 2 | 2021 | 3589 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2018 | 2130 | 0.070 |
Why?
|
| Hypertension, Pulmonary | 1 | 2018 | 1585 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 4421 | 0.070 |
Why?
|
| Pain | 1 | 2022 | 5070 | 0.070 |
Why?
|
| Cold Ischemia | 1 | 2006 | 70 | 0.070 |
Why?
|
| Device Removal | 1 | 2011 | 630 | 0.060 |
Why?
|
| Hospital Mortality | 1 | 2020 | 5296 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2018 | 8478 | 0.060 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2005 | 1425 | 0.060 |
Why?
|
| Muscle Cells | 1 | 2006 | 195 | 0.060 |
Why?
|
| Ventricular Function, Left | 1 | 2018 | 3899 | 0.060 |
Why?
|
| Patient Readmission | 1 | 2019 | 3268 | 0.060 |
Why?
|
| Perfusion | 1 | 2010 | 1390 | 0.060 |
Why?
|
| Myocardium | 1 | 2018 | 4746 | 0.060 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 1790 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 2017 | 2571 | 0.060 |
Why?
|
| Abdomen | 1 | 2010 | 1128 | 0.060 |
Why?
|
| Adolescent | 2 | 2024 | 88271 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2014 | 2165 | 0.060 |
Why?
|
| Electrocoagulation | 1 | 2004 | 152 | 0.060 |
Why?
|
| Recovery of Function | 2 | 2021 | 2981 | 0.060 |
Why?
|
| Rabbits | 2 | 2006 | 4749 | 0.050 |
Why?
|
| Brachiocephalic Veins | 1 | 2003 | 21 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2016 | 3603 | 0.050 |
Why?
|
| Middle Aged | 12 | 2020 | 220835 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 1 | 2014 | 1923 | 0.050 |
Why?
|
| Phenoxybenzamine | 1 | 2002 | 53 | 0.050 |
Why?
|
| Emergencies | 2 | 2011 | 1217 | 0.050 |
Why?
|
| Vascular Surgical Procedures | 1 | 2010 | 1489 | 0.050 |
Why?
|
| Adult | 9 | 2022 | 221083 | 0.050 |
Why?
|
| Infant | 2 | 2022 | 36164 | 0.050 |
Why?
|
| Smoking | 1 | 2018 | 9055 | 0.050 |
Why?
|
| Myocardial Contraction | 1 | 2006 | 1516 | 0.050 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2006 | 854 | 0.050 |
Why?
|
| Vasopressins | 1 | 2002 | 351 | 0.050 |
Why?
|
| Heart Conduction System | 1 | 2006 | 1008 | 0.050 |
Why?
|
| Aortography | 1 | 2002 | 421 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2005 | 869 | 0.040 |
Why?
|
| Models, Animal | 1 | 2006 | 2114 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2010 | 2725 | 0.040 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2019 | 21 | 0.040 |
Why?
|
| Infant, Newborn | 5 | 2010 | 26187 | 0.040 |
Why?
|
| Thorax | 1 | 2022 | 555 | 0.040 |
Why?
|
| Incidental Findings | 1 | 2004 | 698 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2010 | 2092 | 0.040 |
Why?
|
| United States | 4 | 2020 | 72337 | 0.040 |
Why?
|
| Atrioventricular Node | 2 | 2010 | 180 | 0.040 |
Why?
|
| Femoral Artery | 1 | 2022 | 826 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2022 | 1559 | 0.040 |
Why?
|
| Primary Graft Dysfunction | 1 | 2018 | 111 | 0.040 |
Why?
|
| Alprazolam | 1 | 2017 | 103 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2021 | 849 | 0.040 |
Why?
|
| Erythrocyte Transfusion | 1 | 2022 | 570 | 0.040 |
Why?
|
| Graft Rejection | 2 | 2022 | 4479 | 0.040 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2006 | 1312 | 0.030 |
Why?
|
| Diltiazem | 1 | 2017 | 131 | 0.030 |
Why?
|
| Antidotes | 1 | 2017 | 138 | 0.030 |
Why?
|
| Digoxin | 1 | 2017 | 246 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2006 | 1865 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2019 | 1157 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2004 | 1754 | 0.030 |
Why?
|
| Hypotension | 1 | 2002 | 879 | 0.030 |
Why?
|
| Hospitalization | 1 | 2015 | 10712 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2005 | 2106 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2004 | 1396 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2022 | 1303 | 0.030 |
Why?
|
| Gestational Age | 1 | 2004 | 3577 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 3493 | 0.030 |
Why?
|
| Brain Death | 1 | 2018 | 357 | 0.030 |
Why?
|
| Multiple Organ Failure | 1 | 2017 | 387 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2022 | 2381 | 0.030 |
Why?
|
| Troponin I | 1 | 2018 | 652 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 2006 | 3258 | 0.030 |
Why?
|
| Age Factors | 2 | 2021 | 18385 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2018 | 12341 | 0.030 |
Why?
|
| Canada | 1 | 2018 | 2125 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 1837 | 0.030 |
Why?
|
| Electrocardiography | 2 | 2018 | 6385 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 18217 | 0.020 |
Why?
|
| Consensus | 1 | 2021 | 3133 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 39121 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 4947 | 0.020 |
Why?
|
| Bundle of His | 1 | 2010 | 101 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2018 | 41486 | 0.020 |
Why?
|
| Tissue and Organ Procurement | 1 | 2018 | 962 | 0.020 |
Why?
|
| Risk Assessment | 4 | 2018 | 24013 | 0.020 |
Why?
|
| Echocardiography | 2 | 2018 | 5006 | 0.020 |
Why?
|
| Critical Care | 1 | 2022 | 2690 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2011 | 366 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 3689 | 0.020 |
Why?
|
| Animals | 5 | 2022 | 168083 | 0.020 |
Why?
|
| Aged | 5 | 2018 | 169266 | 0.020 |
Why?
|
| Prognosis | 2 | 2019 | 29672 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 463 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6482 | 0.020 |
Why?
|
| Graft Survival | 1 | 2018 | 3841 | 0.020 |
Why?
|
| Heart-Assist Devices | 1 | 2018 | 1288 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 10755 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2011 | 898 | 0.020 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2011 | 866 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 7405 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2010 | 1498 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 2011 | 839 | 0.020 |
Why?
|
| Prosthesis Implantation | 1 | 2010 | 591 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2018 | 4506 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 2757 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2011 | 623 | 0.020 |
Why?
|
| Risk | 1 | 2017 | 9614 | 0.020 |
Why?
|
| Ligation | 1 | 2006 | 446 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 10083 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 613 | 0.020 |
Why?
|
| Patient Participation | 1 | 2014 | 1444 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2006 | 1159 | 0.010 |
Why?
|
| Connexins | 1 | 2006 | 352 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 696 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2006 | 426 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 2006 | 472 | 0.010 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 1424 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2018 | 5520 | 0.010 |
Why?
|
| Aortic Stenosis, Subvalvular | 1 | 2003 | 10 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2006 | 1644 | 0.010 |
Why?
|
| Capillaries | 1 | 2006 | 755 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 2016 | 3743 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 12975 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2018 | 7969 | 0.010 |
Why?
|
| Pregnancy | 1 | 2004 | 29872 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2014 | 3923 | 0.010 |
Why?
|
| Heart Function Tests | 1 | 2002 | 318 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2006 | 1331 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2666 | 0.010 |
Why?
|
| Aortic Valve | 1 | 2010 | 1959 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 2508 | 0.010 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2003 | 477 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2003 | 982 | 0.010 |
Why?
|
| Acute Disease | 1 | 2010 | 7240 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2006 | 1347 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2002 | 20600 | 0.010 |
Why?
|
| Cell Communication | 1 | 2006 | 1650 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2010 | 2751 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2002 | 1818 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 6067 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 6507 | 0.010 |
Why?
|
| Stem Cells | 1 | 2006 | 3512 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11066 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 58946 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2010 | 22157 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 21357 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 36418 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 23713 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 13506 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2006 | 11505 | 0.000 |
Why?
|
| Risk Factors | 1 | 2010 | 74219 | 0.000 |
Why?
|